SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada
5 references·0 citing·26 second hop
Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada (2004)Economic evaluation of therapeutic interv…Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)Costs Associated With the Pri…Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (2002)Lifetime Costs of Complicatio…Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. (1998)Direct Medical Costs of Compl…Canadian Guidelines for Economic Evaluation of Pharmaceuticals (1996)Canadian Guidelines for Econo…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Cost-Effectiveness in Health and Medicine (1996)Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians (2007)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)Meta-Analyses of Randomized Controlled Trials (1987)Costs, effects and C/E‐ratios alongside a clinical trial (1994)A study of the quality of life and cost-utility of renal transplantation (1996)Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1956)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1994)The Use of Consensus Methods and Expert Panels in Pharmacoeconomic Studies (1997)Economic costs of social phobia: A population-based study (2008)Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial (2010)Theory of games and economic behavior (2019)The Economic Costs of Non—Insulin-Dependent Diabetes Mellitus (1989)Health care expenditures for people with diabetes mellitus, 1992. (1994)Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Direct Health Care Costs of Diabetic Patients in Spain (2004)Costs of Stroke Using Patient-Level Data (2008)Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012) (2014)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Pharmacoeconomic Analyses Using Discrete Event Simulation (2005)
this work references cited by second hop

References

  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 2003Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program358 cited
  • 2002Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.258 cited
  • 1998Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S.151 cited
  • 1996Canadian Guidelines for Economic Evaluation of Pharmaceuticals129 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work